2023-02-03 08:22:23 TENX Tenax Therapeutics
02/03/23 02/0308:22 02/03/2308:22 | Tenax Therapeutics announces pricing of approximately $15.6M public offeringTenax Therapeutics announced the pricing of a public offering of 8,666,666 shares of its common stock and warrants to purchase up to 17,333,332 shares of its common stock at a purchase price of $1.80 per share and associated Public Warrant. The Public Warrants will have an exercise price of $2.25 per share, are immediately exercisable, and will expire five years after their initial exercise date. The offering is expected to close on or about February 7, 2023, subject to customary closing conditions. Roth Capital Partners is acting as our exclusive placement agent in the offering. Gross proceeds, before deducting placement agent fees and commissions and offering expenses are expected to be approximately $15.6 million. The Company intends to use the net proceeds from the offering to progress the clinical development of imatinib for the treatment of PAH and levosimendan for the treatment of PH-HFpEF, toward regulatory approval for the treatment of these and potentially other indications and, depending on patents pending that the Company expects the USPTO to make throughout 2023 and other factors determining near-term prioritization, channel the net proceeds towards these ends as well as for working capital, capital expenditures, continued product development, and other general corporate purposes. |
---|
Hot Stocks
|
Puma presents biomarker findings from Phase II study in HR+, TN breast cancer »
09:08 06/04/23 06/0409:08 06/04/2309:08
PBYI
Puma Biotechnology
Puma Biotechnology… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Amgen presents new LUMAKRAS CodeBreaK 200 CNS data at ASCO »
08:48 06/04/23 06/0408:48 06/04/2308:48
AMGN
Amgen
Amgen announced the… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Bristol-Myers presents follow-up results from Phase 3 CheckMate -9LA trial »
08:45 06/04/23 06/0408:45 06/04/2308:45
BMY
Bristol-Myers
Bristol-Myers Squibb… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
ImmunoGen presents results Phase 3 confirmatory MIRASOL trial »
08:41 06/04/23 06/0408:41 06/04/2308:41
IMGN
ImmunoGen
ImmunoGen announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Summit presents data for investigational bispecific antibody ivonescimab »
08:28 06/04/23 06/0408:28 06/04/2308:28
SMMT
Summit Therapeutics
Summit Therapeutics… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
AstraZeneca says TAGRISSO achieved 'unprecedent' survival in EGFRm »
08:24 06/04/23 06/0408:24 06/04/2308:24
AZN
AstraZeneca
AstraZeneca says… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
G1 Therapeutics presents data from Phase 2 study of trilaciclib in TNBC »
07:28 06/04/23 06/0407:28 06/04/2307:28
GTHX
G1 Therapeutics
G1 Therapeutics presented… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Saudi Arabia, some OPEC members clash over production quotas, WSJ reports »
06:37 06/04/23 06/0406:37 06/04/2306:37
BP
BP
ConocoPhillips
Shell
TotalEnergies
Exxon Mobil
Chevron
Saudi Arabia and some… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Bank stocks too beaten down, JPMorgan among those to buy now, Barron's says »
06:29 06/04/23 06/0406:29 06/04/2306:29
JPM
JPMorgan
Citizens Financial
The past three months saw… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Ride not over for Eaton stock, Barron's says »
06:25 06/04/23 06/0406:25 06/04/2306:25
ETN
Eaton
A year ago, the backlog… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
IBM hiding in plain sight, paying big dividend, Barron's says »
06:21 06/04/23 06/0406:21 06/04/2306:21
IBM
IBM
IBM is one of the most… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Twitter loses another senior executive in charge of content, safety, WSJ says »
17:46 06/03/23 06/0317:46 06/03/2317:46
TWTR
A second senior executive… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen Pharmaceuticals announces updated data from Phase 2 TRiMM-2 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen presents analysis of infections, parameters in Monumen-TAL1 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen Pharmaceuticals announced results from Phase 1/2 MonumenTAL-1 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune Group announces 3 trial-in-progress abstracts at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Additional Abstracts… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune presents data from Phase 1 trial of RP2 with nivolumab at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Bristol-Myers
Replimune Group (REPL)… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune presents RP1 data from IGNYTE trial at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Bristol-Myers
Replimune (REPL)… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
| Healthcare Analysts hold… Story temporarily locked. |
Hot Stocks
|
Janssen announces results from Phase 1b RedirecTT-1 study »
17:18 06/03/23 06/0317:18 06/03/2317:18
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Evaxion's trial of EVX-01 met its primary endpoints of safety, tolerability »
17:09 06/03/23 06/0317:09 06/03/2317:09
EVAX
Evaxion Biotech
Evaxion Biotech presented… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Gracell presents long-term follow up data from study evaluating GC012F »
17:07 06/03/23 06/0317:07 06/03/2317:07
GRCL
Gracell
Gracell Biotechnologies… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Sutro Biopharma announces results from Phase 1 dose-expansion study of luvelta »
17:02 06/03/23 06/0317:02 06/03/2317:02
STRO
Sutro Biopharma
Sutro Biopharma announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Equitrans Midstream's Mountain Valley Pipeline to proceed »
16:58 06/03/23 06/0316:58 06/03/2316:58
ETRN
Equitrans Midstream
On June 3, 2023, the… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Cogent Biosciences announces data from ongoing Phase 3 PEAK trial »
16:56 06/03/23 06/0316:56 06/03/2316:56
COGT
Cogent Biosciences
Cogent Biosciences… Story temporarily locked. ShowHide Related Items >><<
|